MYCN and neuroblastoma: To monitor the gene expression in human neuroblastoma and address the impact of MYCN amplification in in vivo metabolic reconstitution, we utilized our established workflow that was previously applied [1] for intratumoral computational transcriptional profiling in neuroblastoma published results [47].